Basics Pyxis Oncology, Inc. IPO Date: October 8, 2021 Sector: Healthcare Industry: Biotech Market Cap: $75.58M Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 4.01% Avg Daily Range (30 D): $0.05 | 4.09% Avg Daily Range (90 D): $0.04 | 3.89% Institutional Daily Volume Avg Daily Volume: .55M Avg Daily Volume (30 D): .4M Avg Daily Volume (90 D): .46M Trade Size Avg Trade Size (Sh.): 175 Avg Trade Size (Sh.) (30 D): 172 Avg Trade Size (Sh.) (90 D): 177 Institutional Trades Total Inst.Trades: 48 Avg Inst. Trade: $2.12M Avg Inst. Trade (30 D): $.93M Avg Inst. Trade (90 D): $.93M Avg Inst. Trade Volume: .53M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.71M Avg Closing Trade (30 D): $.93M Avg Closing Trade (90 D): $.93M Avg Closing Volume: 1.15M     News Jun 28, 2024 @ 8:30 PM Pyxis Oncology Reports Inducement Grants Under Nas... Source: Pyxis Oncology Jun 10, 2024 @ 11:30 AM Pyxis Oncology Expands Board of Directors with App... Source: Pyxis Oncology May 30, 2024 @ 11:30 AM Pyxis Oncology to Participate in a Fireside Chat a... Source: Pyxis Oncology May 14, 2024 @ 12:40 PM Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops ... Source: Zacks Equity Research Apr 12, 2024 @ 1:55 PM Does Pyxis Oncology (PYXS) Have the Potential to R... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-.35 $-.59 $-1.32 Diluted EPS $-.35 $-.59 $-1.32 Revenue $ $ M $ 16.15M Gross Profit $ $ M $ 15.67M Net Income / Loss $ -21.16M $ -35.57M $ -77.33M Operating Income / Loss $ -22.91M $ -40.07M $ -89.46M Cost of Revenue $ $ M $ .48M Net Cash Flow $ M $ 7.42M $ 9.81M PE Ratio